文献速递关节外科创伤骨科

超越革兰阴性/阳性:毒力是假体周围感染临床结局的决定因素

Beyond Gram-Negative and Gram-Positive Bacteria: Virulence as a Determinant of Clinical Outcome in Periprosthetic Joint Infections.
PubMed 文献 · J Arthroplasty · 2026-02-24

该回顾性匹配队列研究纳入2008至2024年单中心1695例培养阳性髋膝关节翻修术,按EBJIS标准确诊PJI,排除混合GN/GP及厌氧感染,经1:3倾向评分匹配后比较GN与GP PJI结局。GN PJI结局显著劣于GP PJI(P=0.032),再感染风险高1.64倍;高毒力GP PJI与GN PJI结局无统计学差异(P=0.73)。

要点

  • GN PJI结局显著劣于GP PJI,再感染风险高1.64倍。
  • 高毒力GP PJI与GN PJI结局无统计学差异,毒力同等重要。
  • GN PJI中单阶段手术成功率最高(62.5%),DAIR最低(30.8%)。

核心结论

  • GN PJI结局显著劣于GP PJI,但高毒力GP PJI与GN PJI结局相同,提示毒力在决定PJI结局中起同等重要作用。

研究设计与样本

  • 单中心回顾性匹配队列研究,评估2008至2024年1695例培养阳性髋膝关节翻修术,纳入EBJIS标准确诊PJI,排除混合GN/GP及厌氧感染,采用1:3倾向评分匹配(匹配Charlson合并症指数、年龄、性别、髋/膝)。

主要发现

  • GN PJI结局显著劣于GP PJI(P=0.032),再感染风险高1.64倍。
  • 高毒力GN/GP PJI结局显著劣于低毒力PJI。
  • 高毒力GP PJI与GN PJI比较无统计学差异(P=0.73)。
  • GN PJI中单阶段手术成功率最高(62.5%),DAIR最低(30.8%)。
  • GN病原体氟喹诺酮耐药率高达24%,但氟喹诺酮治疗未提高成功率(P=0.214)。

关键数值与推荐

  • GP PJI中低毒力150/252(59.5%),高毒力102/252(40.5%)。
  • 结局采用MSIS Tier分类判定。

临床怎么用

  • 临床评估PJI预后时应考虑病原体毒力,而非仅区分革兰阴性/阳性。
  • GN PJI中单阶段手术成功率最高,DAIR最低,决策时可参考。
  • 氟喹诺酮耐药率高达24%且治疗未提高成功率,经验性使用需谨慎。

局限性

  • 单中心回顾性设计。
  • 排除混合GN/GP及厌氧感染,结论不适用于这些人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gram-negative (GN) periprosthetic joint infections (PJIs) are still less frequent than gram-positive (GP) PJIs. There is only little data available on a direct comparison of GP- and GN-associated PJIs. Therefore, we investigated the outcome of GN and GP hip and knee PJI according to the virulence of the pathogens in a matched cohort. METHODS: We retrospectively evaluated 1,695 culture-positive revision hip and knee arthroplasties from a single institution performed between 2008 and 2024. Infection-confirmed PJIs, according to the European Bone and Joint Infection Society criteria, were included. Polymicrobial cases with mixed GN and GP pathogens and anaerobic infections were excluded. A 1:3 propensity score matching for Charlson Comorbidity Index, age, sex, hip, and knee was performed using logistic regressions. The GP PJIs were divided into low (150 of 252; 59.5%) and high-virulent pathogens (102 of 252; 40.5%). Outcomes were determined using the Tier classification by the Musculoskeletal Infection Society. RESULTS: The GN PJIs demonstrated a significantly worse outcome than GP PJIs (P = 0.032) and a 1.64-fold higher risk of reinfection. High-virulent GN/GP PJIs have shown a significantly worse outcome than low-virulent PJIs. There was no statistical significance identified when comparing high-virulent GP PJIs and GN PJIs (P = 0.73). In GN PJIs, single-stage procedures showed the highest success rate (62.5%), whereas debridement, antibiotics, and implant retention showed the lowest (30.8%). Resistance to fluoroquinolones was observed in up to 24% of GN pathogens. However, treatment with fluoroquinolones did not result in a higher success rate (P = 0.214). CONCLUSIONS: To our knowledge, this is the first study comparing GN PJIs and GP PJIs based on their virulence, demonstrating that GN PJIs have a significantly worse outcome than GP PJIs. However, high-virulent GP PJIs have shown the same outcome as GN PJIs, suggesting that virulence plays an equally important role in determining the outcome of PJIs.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Achatz V, Sebastian S, Mitterer JA, et al. Beyond Gram-Negative and Gram-Positive Bacteria: Virulence as a Determinant of Clinical Outcome in Periprosthetic Joint Infections. J Arthroplasty. 2026. PMID: 41740810. doi:10.1016/j.arth.2026.02.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。